Arkolith/Insider Trading/JAZZ/Form 4

Cozadd Bruce C

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Nov 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.3M
Net Open-Market Flow
-$3.3M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2025Grant(A)3K—$0393K
Nov 18, 2025Sell(S)3K$180.09$609K405K
Nov 18, 2025Sell(S)6K$181.81$1.0M392K
Nov 18, 2025Sell(S)717$182.60$131K391K
Nov 18, 2025Sell(S)8K$180.88$1.5M397K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193210-25-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML